I lead a translational research programme focused on biology-guided optimisation of therapeutic and device-based interventions to improve tissue resilience and repair. This includes work on chemotherapy-induced toxicity (e.g. scalp and limb cooling strategies) as well as regenerative approaches such as autologous skin cell suspension technologies (VeritaCell platform). Across these areas, the central aim is to define how biological mechanisms (such as oxidative stress, cellular metabolism, and tissue regeneration) can be leveraged to enhance clinical efficacy and enable real-world translation.